Our #KCRS24 meeting starts tomorrow with KEYNOTE SPEAKER Prof Charles Swanton KidneyCAN OncoAlert OncLive.com Targeted Oncology Register now: kcrs.kidneycan.org/kidney-cancer-…

Anti-tumor efficacy of HRS-4642 and its potential combination with proteasome inhibition in KRAS G12D-mutant cancer dlvr.it/T9QbM5

Spatiotemporal single-cell analysis decodes cellular dynamics underlying different responses to immunotherapy in colorectal cancer dlvr.it/T9R2CT

#OpenAccess in Cancer Discovery - with new KRASi; it’s important to understand mechanisms of resistance in #PancreaticCancer such as EMT and PI3K-AKT-mTOR signaling. Combination therapies show promise. #pancsm 💜 OncoAlert 🚨 aacrjournals.org/cancerdiscover…

Are 🫵🏻 ready to shine some light on the value of PD-L1 in #GastricCancer? 👀 to the 🌏 EORTC ASPIRE project 🎯harmonise PD-L1 results in GC ➡️ better patients selection for #immunotherapy Lizzy Smyth Raghav Sundar ESMO - Eur. Oncology #EORTC #GITCG #biomarker #ESMOGIoncology #TIP

That time of the year has finally arrived 🤩🎉🥳 …our ESMO - Eur. Oncology President Andres Cervantes opening the #ESMO Course in Medical Oncology for Medical Students !!! OncoAlert #ESMOYOC francescalongo Katharine Fumasoli FabriceAndre Solange Peters G Curigliano MD PhD Università di Genova Ospedale San Martino Genova

What a fantastic #ESMO Course in Medical Oncology for Medical Students…really grateful to our ESMO - Eur. Oncology President Andres Cervantes, the exceptional ESMO - Eur. Oncology staff and the super faculty for such an outstanding event !!! OncoAlert #ESMOYOC John Haanen Università di Genova Ospedale San Martino Genova

Meta-analysis of 24 randomized controlled trials demonstrates an increased risk of CV events amongst patients with advanced and metastatic prostate cancer commencing androgen receptor signaling inhibitors. ja.ma/3LBSGYJ

El CIPF e INCLIVA firman el convenio de colaboración para la investigación en cáncer de mama "Beca Ana Lluch" 2025-2028 #másinvestigación #mejorsalud #cáncerdemama

New #JITC article: rhIL-7-hyFc, a long-acting interleukin-7, improves efficacy of CAR-T cell therapy in solid tumors bit.ly/4cQBue7 Mitchell Ho, PhD

NEW content online! Enhancing cellular immunotherapies in cancer by engineering selective therapeutic resistance go.nature.com/4d9hpzu

🚨🥁ANNOUNCEMENT: Precision medicine & tumor-agnostic drug development take center stage ESMO - Eur. Oncology #ESMO24 ! ‼️👉Honored to be invited to speak at the SPECIAL ESMO & ASCO joint session in Barcelona, Spain on "Tumour-agnostic drug development" at the ESMO congress 2024. 👉Chaired

Colorectal cancer is not a single disease but a complex collection of subtypes with unique genomic landscapes. Whole-genome sequencing of 2,023 samples sheds light on the molecular diversity of CRC. Researchers identify 4 new subgroups of microsatellite-stable CRCs with distinct

Tumor-infiltrating lymphocytes: A new hope dlvr.it/TBvmnY

Longitudinal on-treatment circulating tumor DNA as a biomarker for real-time dynamic risk monitoring in cancer patients: The EP-SEASON study dlvr.it/TBwKW8

Congrats Toni Choueiri, MD Tom Powles Laurence Albiges Brian Rini, MD Guillermo de Velasco et al. for a practice-changing trial! ESMO - Eur. Oncology NEJM important milestone for advanced RCC! Sumanta K. Pal, MD, FASCO Neeraj Agarwal, MD, FASCO Brian Shuch, MD Karine Tawagi MD OncoAlert Oncology Brothers Kidney Cancer Evan Hall Shailender Bhatia, MD

In Naples 🇮🇹 for ESMO - Eur. Oncology Course in Med Onc for Med Stu 🎓. This year, we have 60+ students from 29 countries. Always so refreshing to get to know & hear from young fresh minds, excited for the future of oncology! Day 1 ☑️! Andres Cervantes Pawel Sobczuk Maria Kfoury Alberto Servetto

ESMO - Eur. Oncology Cristina Saura Giulia Martini Floriana Morgillo Fabio Gomes Noelia Tarazona *🆕* in 2024 programme, we’ve created a session on ‘A Window into the Future of Oncology’, covering: 🚀 Circulating biomarkers Andres Cervantes 🚀 Novel immunotherapy strategies Jon Lim 🚀 AI/ML Pawel Sobczuk Hope these showcase what’s on the horizon in our exciting field!

ESMO - Eur. Oncology Cristina Saura Giulia Martini Floriana Morgillo Fabio Gomes Noelia Tarazona Andres Cervantes Pawel Sobczuk Final Day: Today we had a ‘roundtable’ re: career development in oncology - great to sense excitement from our next gen! A great honour for me to deliver the final lecture on a topic close to my heart, in such a historical venue UniversitàVanvitelli re: #ClinicianScientists in oncology.

ESMO - Eur. Oncology Cristina Saura Giulia Martini Floriana Morgillo Fabio Gomes Noelia Tarazona Andres Cervantes Pawel Sobczuk UniversitàVanvitelli Last but not least, it’s been a great privilege to co-chair the 2024 ESMO Course in Med Onc for Med Stu 🎓 with our ESMO - Eur. Oncology President Andres Cervantes. We’ve had a lovely time interacting with such motivated and enthusiastic students. Thank you to all faculty! Till next year!